ZA986138B - Combinations of selective serotonin re-update inhibitors and B-blockers. - Google Patents
Combinations of selective serotonin re-update inhibitors and B-blockers.Info
- Publication number
- ZA986138B ZA986138B ZA9806138A ZA986138A ZA986138B ZA 986138 B ZA986138 B ZA 986138B ZA 9806138 A ZA9806138 A ZA 9806138A ZA 986138 A ZA986138 A ZA 986138A ZA 986138 B ZA986138 B ZA 986138B
- Authority
- ZA
- South Africa
- Prior art keywords
- blockers
- inhibitors
- update
- combinations
- selective serotonin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA986138B true ZA986138B (en) | 2000-01-10 |
Family
ID=10815744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9806138A ZA986138B (en) | 1997-07-11 | 1998-07-10 | Combinations of selective serotonin re-update inhibitors and B-blockers. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0996466A2 (en) |
| JP (1) | JP2002508003A (en) |
| KR (1) | KR20010021644A (en) |
| CN (1) | CN1262627A (en) |
| AP (1) | AP2000001728A0 (en) |
| AR (1) | AR016128A1 (en) |
| AU (1) | AU9340198A (en) |
| BG (1) | BG104119A (en) |
| BR (1) | BR9810996A (en) |
| CA (1) | CA2295822A1 (en) |
| CO (1) | CO4950552A1 (en) |
| DZ (1) | DZ2556A1 (en) |
| EA (1) | EA200000112A1 (en) |
| GB (1) | GB9714675D0 (en) |
| HU (1) | HUP0003074A3 (en) |
| ID (1) | ID24191A (en) |
| IL (1) | IL133869A0 (en) |
| MA (1) | MA24604A1 (en) |
| NO (1) | NO20000107D0 (en) |
| OA (1) | OA11276A (en) |
| PE (1) | PE99699A1 (en) |
| PL (1) | PL338017A1 (en) |
| SK (1) | SK72000A3 (en) |
| TR (1) | TR200000074T2 (en) |
| WO (1) | WO1999002142A2 (en) |
| ZA (1) | ZA986138B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE457169T1 (en) | 1998-10-15 | 2010-02-15 | Imp Innovations Ltd | COMPOUNDS FOR THE TREATMENT OF WEIGHT LOSS |
| PT1126826E (en) | 1998-11-02 | 2008-11-25 | Elan Pharma Int Ltd | Multiparticulate modified release composition of methylphenidate |
| KR101476574B1 (en) | 1999-10-29 | 2014-12-24 | 유로-셀티크 소시에떼 아노뉨 | Controlled release hydrocodone formulations |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
| MXPA03003895A (en) | 2000-10-30 | 2003-07-28 | Euro Celtique Sa | Controlled release hydrocodone formulations. |
| WO2006030306A2 (en) * | 2004-09-17 | 2006-03-23 | Neurocure Ltd | Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| CN100469356C (en) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | Slowly released tablet of compound atenolol, and preparation method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732335C2 (en) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablet for the enteral administration of indolyloxyalkanolamine derivatives |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug response by a serotonin 1A receptor antagonist |
| DE69607904T2 (en) * | 1995-08-16 | 2000-10-05 | Lilly Co Eli | Potentiation of serotonin drug response |
| EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 SK SK7-2000A patent/SK72000A3/en unknown
- 1998-07-07 CN CN98806975A patent/CN1262627A/en active Pending
- 1998-07-07 PL PL98338017A patent/PL338017A1/en unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/en unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 IL IL13386998A patent/IL133869A0/en unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/en unknown
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/en not_active Application Discontinuation
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 EA EA200000112A patent/EA200000112A1/en unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/en unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/en active Pending
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/en not_active Application Discontinuation
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/en active
- 1998-07-10 AR ARP980103371A patent/AR016128A1/en unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/en unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/en unknown
- 1998-07-10 MA MA25165A patent/MA24604A1/en unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/en not_active Application Discontinuation
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107D0/en not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9810996A (en) | 2000-08-08 |
| PL338017A1 (en) | 2000-09-25 |
| IL133869A0 (en) | 2001-04-30 |
| CA2295822A1 (en) | 1999-01-21 |
| SK72000A3 (en) | 2000-12-11 |
| OA11276A (en) | 2003-07-31 |
| CO4950552A1 (en) | 2000-09-01 |
| HUP0003074A2 (en) | 2001-01-29 |
| HUP0003074A3 (en) | 2001-12-28 |
| PE99699A1 (en) | 1999-12-21 |
| AU9340198A (en) | 1999-02-08 |
| ID24191A (en) | 2000-07-13 |
| AR016128A1 (en) | 2001-06-20 |
| JP2002508003A (en) | 2002-03-12 |
| DZ2556A1 (en) | 2003-02-15 |
| WO1999002142A2 (en) | 1999-01-21 |
| MA24604A1 (en) | 1999-04-01 |
| CN1262627A (en) | 2000-08-09 |
| GB9714675D0 (en) | 1997-09-17 |
| NO20000107L (en) | 2000-01-10 |
| NO20000107D0 (en) | 2000-01-10 |
| KR20010021644A (en) | 2001-03-15 |
| AP2000001728A0 (en) | 2000-03-31 |
| EP0996466A2 (en) | 2000-05-03 |
| TR200000074T2 (en) | 2000-05-22 |
| WO1999002142A3 (en) | 1999-04-15 |
| EA200000112A1 (en) | 2000-10-30 |
| BG104119A (en) | 2000-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA973146B (en) | Prodrugs of COX-2 inhibitors. | |
| ID23983A (en) | AMINOTIAZOL INHIBITORS FOR CINCINES DEPENDING ON CYCLINES | |
| HK1049630A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same. | |
| ZA975335B (en) | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors. | |
| ZA973397B (en) | Inhibitors of IMPDH enzyme. | |
| ZA985778B (en) | Inhibitors of farnesyl protein transferase. | |
| NO20001651L (en) | Downloading data | |
| DE69820138D1 (en) | Method pour stimuler des formations souterraines non consolidees | |
| PL364704A1 (en) | Enzyme inhibitors | |
| ZA200109994B (en) | Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors. | |
| DK1027332T3 (en) | New lactametalloprotease inhibitors | |
| ID20637A (en) | METHODS FOR INHIBITING THE FORMATION OF BIOGENIC SULFIDA | |
| EP1140791A4 (en) | Selective cpla 2 inhibitors | |
| NO20012691D0 (en) | Isomerization of hydrocarbons | |
| HUP0101640A3 (en) | Certain thoil inhibitors of endothelin-converting enzyme | |
| NO996090L (en) | Improved fishing lining and method for using it | |
| ZA986138B (en) | Combinations of selective serotonin re-update inhibitors and B-blockers. | |
| ZA977868B (en) | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors. | |
| TR199501644A2 (en) | Squalene synthase inhibitors. | |
| ZA991575B (en) | N-sulphonyl and N-sulphinyl phenylglycinamide. | |
| GB9816358D0 (en) | Enzyme inhibitors | |
| ITBO970057A0 (en) | METHOD OF CHECKING CIGARETTES. | |
| EE9900455A (en) | New procedure | |
| NO20001569D0 (en) | Bisethers of 1-oxa, aza and thianaphthalene-2-ones as phospholamban inhibitors | |
| ZA200110325B (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same. |